Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bedenne

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
Gastroenterologie Clinique Et Biologique|January 1, 1990
[Preliminary results of a mass screening program for colorectal cancer]L Bedenne, G Durand, J Faivre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2009
Surrogate end points for overall survival and local control in neoadjuvant rectal cancer trials: statistical evaluation based on the FFCD 9203 trialN Methy, L Bedenne, T Conroy, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1990
[Is the Tru-Cut needle more efficient than the fine needle in the diagnosis of hepatic lesions? Comparative study of 45 echography-guided punctures]L Bedenne, C Mottot, B Courtois, et al.
Bulletin Du Cancer|January 1, 1988
[Colorectal cancers disclosed by an obstruction. Frequency and prognosis in a population]M C Boutron, J Faivre, H Rallier du Baty, et al.
European Journal of Nuclear Medicine|June 1, 2001
131I thyroid uptake in patients treated with 131I-Lipiodol for hepatocellular carcinomaM Toubeau, C Touzery, A Berriolo-Riedinger, et al.
Gastroenterologie Clinique Et Biologique|March 29, 2008
Endoscopic ultrasonography is an independent predictive factor of prognosis in locally advanced esophageal cancer. Results from the randomized FFCD 9102 study from the Fédération Francophone de Cancérologie DigestiveP Burtin, O Bouché, M Giovannini, et al.
Gastroenterologie Clinique Et Biologique|October 8, 1998
[Cisplatin, 5-FU and preoperative radiotherapy in esophageal epidermoid cancer. Multicenter phase II FFCD 8804 study]L Bedenne, J F Seitz, C Milan, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1989
Rioprostil and ranitidine in the prevention of duodenal ulcer relapseP Rampal, A Raillat, J M Viteau, et al.
Anti-Cancer Drugs|November 15, 2001
Increased cytotoxicity and stability of Lipiodol-pirarubicin emulsion compared to classical doxorubicin-Lipiodol: potential advantage for chemoembolization of unresectable hepatocellular carcinomaP Favoulet, J P Cercueil, P Faure, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2008
Prognosis of advanced hepatocellular carcinoma: comparison of three staging systems in two French clinical trialsS Collette, F Bonnetain, X Paoletti, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Gastroenterologie Clinique Et Biologique|January 1, 1990
[Preliminary results of a mass screening program for colorectal cancer]L Bedenne, G Durand, J Faivre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2009
Surrogate end points for overall survival and local control in neoadjuvant rectal cancer trials: statistical evaluation based on the FFCD 9203 trialN Methy, L Bedenne, T Conroy, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1990
[Is the Tru-Cut needle more efficient than the fine needle in the diagnosis of hepatic lesions? Comparative study of 45 echography-guided punctures]L Bedenne, C Mottot, B Courtois, et al.
Bulletin Du Cancer|January 1, 1988
[Colorectal cancers disclosed by an obstruction. Frequency and prognosis in a population]M C Boutron, J Faivre, H Rallier du Baty, et al.
European Journal of Nuclear Medicine|June 1, 2001
131I thyroid uptake in patients treated with 131I-Lipiodol for hepatocellular carcinomaM Toubeau, C Touzery, A Berriolo-Riedinger, et al.
Gastroenterologie Clinique Et Biologique|March 29, 2008
Endoscopic ultrasonography is an independent predictive factor of prognosis in locally advanced esophageal cancer. Results from the randomized FFCD 9102 study from the Fédération Francophone de Cancérologie DigestiveP Burtin, O Bouché, M Giovannini, et al.
Gastroenterologie Clinique Et Biologique|October 8, 1998
[Cisplatin, 5-FU and preoperative radiotherapy in esophageal epidermoid cancer. Multicenter phase II FFCD 8804 study]L Bedenne, J F Seitz, C Milan, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1989
Rioprostil and ranitidine in the prevention of duodenal ulcer relapseP Rampal, A Raillat, J M Viteau, et al.
Anti-Cancer Drugs|November 15, 2001
Increased cytotoxicity and stability of Lipiodol-pirarubicin emulsion compared to classical doxorubicin-Lipiodol: potential advantage for chemoembolization of unresectable hepatocellular carcinomaP Favoulet, J P Cercueil, P Faure, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2008
Prognosis of advanced hepatocellular carcinoma: comparison of three staging systems in two French clinical trialsS Collette, F Bonnetain, X Paoletti, et al.
Pageof 9